Oncolys BioPharma, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3202170001
JPY
911.00
-28 (-2.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1127271,
    "name": "Oncolys BioPharma, Inc.",
    "stock_name": "Oncolys BioPharma, Inc.",
    "full_name": "Oncolys BioPharma, Inc.",
    "name_url": "stocks-analysis/oncolys-biopharma-inc",
    "exchange": 121,
    "exchangecode": "TKS",
    "country_id": 23,
    "currency": "JPY",
    "cmp": "911.00",
    "chg": -28,
    "chgp": "-2.98%",
    "dir": -1,
    "prev_price": "939.00",
    "mcapval": "16,150.16",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "Japan Nikkei 225",
    "isin": "JP3202170001",
    "curr_date": "Dec 11",
    "curr_time": "",
    "bse_nse_vol": "1.42 M",
    "exc_status": "Active",
    "traded_date": "Dec 11, 2025",
    "traded_date_str": "2025 12 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/oncolys-biopharma-inc-1127271-121&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Oncolys BioPharma Hits Day High with Strong 7.06% Intraday Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oncolys-biopharma-hits-day-high-with-strong-706-intraday-surge-3680341",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OncolysBioPharm_priceRelatedfactors_3680341.png",
        "date": "2025-11-07 17:03:33",
        "description": "Oncolys BioPharma, Inc. has seen a notable rise in stock performance, contrasting with a decline in the Japan Nikkei 225 index. Over the past week and month, the stock has shown significant gains, although long-term challenges persist, including a decline in five-year performance and negative financial metrics."
      },
      {
        "title": "Oncolys BioPharma Hits Day High with 7.94% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oncolys-biopharma-hits-day-high-with-794-surge-in-stock-price-3667496",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OncolysBioPharm_priceRelatedfactors_3667496.png",
        "date": "2025-11-03 18:10:46",
        "description": "Oncolys BioPharma, Inc. has seen a notable increase in stock performance today, reaching an intraday high. While the company has achieved a significant year-to-date gain, its long-term performance reveals substantial declines. Additionally, it faces challenges such as negative return on equity and low operating profit growth."
      },
      {
        "title": "Oncolys BioPharma Hits Day Low of JPY 774 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oncolys-biopharma-hits-day-low-of-jpy-774-amid-price-pressure-3623338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/OncolysBioPharm_priceRelatedfactors_3623338.png",
        "date": "2025-10-15 18:22:44",
        "description": "Oncolys BioPharma, Inc. saw its stock price decline significantly today, reaching an intraday low amid a challenging trading environment. Despite a strong annual performance, the company's financial metrics reveal issues with management efficiency and negative earnings, raising concerns about its short-term stability in the biotechnology sector."
      }
    ],
    "total": 3,
    "sid": "1127271",
    "stock_news_url": "https://www.marketsmojo.com/news/oncolys-biopharma-inc-1127271"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available